|
| Status |
Public on Oct 02, 2018 |
| Title |
Ikarugamycin blocks the glycolysis in pancreatic cancer |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
Analysis of gene alterations in PANC-1 cells treated with different concentration of Ikarugamycin (Ika). A broad variety of biological activities of IKA has been reported, such as immune regulation, cytotoxic properties, anti-tumor effects and other pharmacological effects. This study provides insight into molecular basis of Ika in pancreatic cancer.
|
| |
|
| Overall design |
Three 500 nM Ika-treated PANC-1 cells, three 1.5 μM Ika-treated PANC-1 cells and three untreated controls.
|
| |
|
| Contributor(s) |
Shuheng J, Minjuan X |
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Oct 01, 2018 |
| Last update date |
Oct 03, 2018 |
| Contact name |
Shuheng Jiang |
| E-mail(s) |
15133969880@126.com
|
| Organization name |
Shanghai Cancer Institute
|
| Street address |
800 Dongchuan Road
|
| City |
Shanghai |
| ZIP/Postal code |
200240 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL17077 |
Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version) |
|
| Samples (9)
|
|
| Relations |
| BioProject |
PRJNA494233 |
Less...
More...